What are the common causative organisms of blood transfusion infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Causative Organisms of Blood Transfusion Infections

Bacterial contamination of blood products, most frequently platelets, is the leading cause of death from blood transfusions, while viral infections including hepatitis B, hepatitis C, and HIV remain important but now rare risks due to modern screening. 1

Bacterial Infections: The Leading Cause of Transfusion-Related Deaths

Bacterial contamination represents the most common infectious cause of transfusion-related mortality. 1 This occurs most frequently with platelet products due to their storage temperature of 20-24°C, which promotes bacterial overgrowth. 1

Key Clinical Features:

  • Fever developing within 6 hours after receiving platelets suggests possible sepsis from contaminated products 1
  • Many blood banks now culture platelet concentrates routinely to detect contamination 1
  • Coagulase-negative staphylococci are the most common bacterial pathogens, accounting for 37% of hospital-acquired bloodstream infections 1
  • Staphylococcus aureus accounts for 12.6% of transfusion-related bloodstream infections, with >50% now resistant to oxacillin 1
  • Enterococci represent 13.5% of cases, with 25.9% resistant to vancomycin 1

Viral Infections: Now Rare But Still Relevant

Hepatitis Viruses

Hepatitis C virus (HCV) was historically the most common viral infection transmitted by transfusion, with prevalence rates in thalassemia patients ranging from 4.4% to 85.4% before modern screening. 1 The current risk of HCV transmission is estimated at less than 2.5 per 1 million donations in developed countries. 1

Hepatitis B virus (HBV) transmission risk has been reduced to approximately 0.002% per transfusion recipient through HBsAg screening and nucleic acid technology. 1 The prevalence in multiply-transfused patients ranges from 0.3% to 5.7%. 1

Hepatitis E virus (HEV) has emerged as an important transfusion-transmitted pathogen, with viraemic donor frequencies ranging from 1:600 in the Netherlands to 1:74,131 in Australia. 1 Transfusion-transmitted HEV infection occurs in approximately 42-50% of recipients receiving infected blood components with sufficient viral load. 1

Retroviruses

Human immunodeficiency virus (HIV) transmission risk is now extremely low due to nucleic acid technology screening, though it remains a concern during the window period. 1, 2

Human T-cell leukemia/lymphoma virus (HTLV) I and II can be transmitted through transfusion, though screening has drastically reduced this risk. 2, 3, 4

Other Viral Pathogens

  • Cytomegalovirus (CMV): 30-50% of adults have serologic evidence of past infection, posing risks to immunocompromised recipients and pregnant women 2, 3
  • Epstein-Barr virus (EBV): Can cause lymphoproliferative disorders in immunocompromised patients 3
  • Parvovirus B19: May cause severe infections in pregnant women and immunodeficient individuals 2

Parasitic and Other Infections

Malaria, Chagas disease, and variant Creutzfeldt-Jakob disease cannot currently be detected by standard screening tests. 1 These remain potential risks in endemic areas or from donors with relevant exposure history.

  • Plasmodium species (malaria) 4
  • Trypanosoma cruzi (Chagas disease) 1, 4
  • Toxoplasma gondii 4
  • Treponema pallidum (syphilis): Seropositivity rate of 0.02% in screened donors 4, 5

Critical Clinical Pitfall

The most important caveat is that general anesthesia may mask symptoms of transfusion reactions, including fever, chills, and urticaria that would alert clinicians to bacterial contamination or other infectious complications. 1, 6 Therefore, periodic monitoring for signs including hypotension, tachycardia, hyperthermia, and decreased urine output is essential even in anesthetized patients. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Viral risks associated with blood transfusion].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine, 1993

Research

[The blood-born viral infections].

Rinsho byori. The Japanese journal of clinical pathology, 1998

Research

[Risk of transmission of infectious diseases by transfusion].

Ginecologia y obstetricia de Mexico, 1998

Guideline

Management of Blood Transfusion Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.